Alterity Therapeutics (ATHE) Shares Outstanding (2016 - 2025)

Alterity Therapeutics has reported Shares Outstanding for 10 years, with the latest figure at $5.2 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding fell 4.63% year-over-year to $5.2 million; the trailing twelve-month figure through Dec 2025 stood at $5.2 million (down 4.63% YoY), and the FY2025 full-year result was $5.8 billion, up 69.11% from the prior year.
• Shares Outstanding for Q4 2025 stood at $5.2 million, down from $5.8 billion in the prior quarter.
• The five-year high for Shares Outstanding was $5.8 billion in Q2 2025, with the low at $1.6 billion in Q2 2021.
• Average Shares Outstanding over 5 years is $2.9 billion, with a median of $1.7 billion recorded in 2022.
• Year-over-year, Shares Outstanding soared 765493.26% in 2023 and slumped 99.97% in 2025.
• Tracing ATHE's Shares Outstanding over 5 years: stood at $6.3 million in 2021, then decreased by 19.25% to $5.1 million in 2022, then retreated by 18.82% to $4.1 million in 2023, then surged by 32.02% to $5.5 million in 2024, then fell by 4.63% to $5.2 million in 2025.
• The last three Shares Outstanding figures came in at $5.2 million (Q4 2025), $5.8 billion (Q2 2025), and $5.5 million (Q4 2024), per Business Quant data.

Peer Comparison